MAIA Biotechnology Inc. (MAIA) Stock Analysis

MAIA Biotechnology Inc. (MAIA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.35, carries a market capitalization of $79.04M. This page summarizes the public market data, fundamentals, and frequently asked questions for MAIA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.35
• Market Cap: $79.04M
• EPS: $-0.68
• 52-Week High: $3.19
• 52-Week Low: $0.87

Market Sentiment

MAIA Biotechnology Inc. currently has a Bullish sentiment score of 0.30.

About MAIA Biotechnology Inc.

None

GNG Research Analysis

GNG Research scores MAIA Biotechnology Inc. (MAIA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MAIA.

Frequently Asked Questions

Does MAIA pay dividends?

MAIA Biotechnology Inc. (MAIA) does not currently pay a regular dividend.

What is MAIA's market cap?

MAIA Biotechnology Inc. (MAIA) has a market capitalization of $79.04M with a current stock price of $1.35.